Join EHC 2026 Annual Conference
EHC – European Haemophilia Consortium shared a post on LinkedIn:
”Join us at the EHC 2026 Annual Conference in Istanbul, hosted by Turkish Hemophilia Society.
Although von Willebrand Disease (VWD) is the most common inherited bleeding disorder, it’s still too often overlooked, leading to real challenges in diagnosis, treatment, and long-term care.
Don’t miss this dedicated session exploring the most important topics affecting people living with VWD today:
- Jeroen Eikenboom (Leiden University) provides an update on the latest developments in VWD treatment
- Sebastien L. (Cliniques Universitaires Saint-Luc) examines the relationship between joint health and VWD
- Milica Dimic brings the patient voice to the discussion, sharing her perspective on prophylaxis and the impact treatment decisions can have on daily life
By combining scientific advances with patient experience, this session offers valuable insights into the evolving landscape of VWD care and the importance of a more personalised approach to treatment.
Don’t miss this opportunity to be part of the conversation.
Stay updated with Hemostasis Today.
-
Aug 21, 2026, 14:32Kenneth Nollet: Building the Future of Transfusion Laboratory Science
-
Aug 21, 2026, 14:14Tareq Abadl: A Positive Antibody Screen is Not The Diagnosis
-
Aug 21, 2026, 14:08Katrina Snow։ Transfusion Trends and Quality Improvement in Sickle Cell Disease
-
Aug 21, 2026, 14:00Rucha Patil: The Power of Point-of-Care Testing in Hemostasis
-
Aug 21, 2026, 13:56Sarah Kowalski։ Supporting the Next Generation of Transfusion Laboratory Scientists
-
Aug 21, 2026, 12:57David McIntosh: Why Do Blood Supplies Still Fall Short?
-
Aug 21, 2026, 12:48Joshua Penrod: 35 Years of Progress in Plasma Safety
-
Aug 21, 2026, 12:42Moustafa Abdou: Diagnosis and Management of Pyruvate Kinase Deficiency
-
Aug 21, 2026, 12:38Luluva Ghadiyali: Modern Approaches to Aplastic Anemia